ライフサイエンスコーパス: opportunistic infection

1 there were no episodes of acute rejection or opportunistic infection.

2 esult of infection during treatment; one had opportunistic infection.

3 associated with NeuroAIDS in the context of opportunistic infection.

4 associated with an increased risk of serious opportunistic infection.

5 on, each had a single clinically significant opportunistic infection.

6 es gammadeltaT cell-mediated protection from opportunistic infection.

7 d commonly lead to end-organ dysfunction and opportunistic infection.

8 and humoral immunity and protection against opportunistic infection.

9 , and daily co-trimoxazole for prevention of opportunistic infections.

10 nfrequently associated with human and animal opportunistic infections.

11 virus type 1 coinfection without documented opportunistic infections.

12 iciency virus (HIV)-exposed infants to avoid opportunistic infections.

13 n or immune deficiency and can manifest with opportunistic infections.

14 immune system, including disorders involving opportunistic infections.

15 D4(+) T-cell counts that can lead to serious opportunistic infections.

16 s regarding rejection, graft loss, death, or opportunistic infections.

17 he occurrence of associated life-threatening opportunistic infections.

18 ion, perturbation of immune-cell subsets and opportunistic infections.

19 eir interplay with other immune cells during opportunistic infections.

20 making sufferers vulnerable to all manner of opportunistic infections.

21 e diagnosis and management of HIV-associated opportunistic infections.

22 clinical or laboratory evidence, or both, of opportunistic infections.

23 f 57 HIV-infected individuals without ocular opportunistic infections.

24 Fungal pathogens are a frequent cause of opportunistic infections.

25 ights into tuberculosis, HIV/AIDS, and other opportunistic infections.

26 control GVHD and increase susceptibility to opportunistic infections.

27 nt differences in terms of the occurrence of opportunistic infections.

28 s and, presumably, susceptibility to certain opportunistic infections.

29 revent and treat HIV-1 infection and related opportunistic infections.

30 epsis become immunosuppressed and succumb to opportunistic infections.

31 recovery, resulting in an increased risk of opportunistic infections.

32 SCT) is limited by patient susceptibility to opportunistic infections.

33 CD4(+) T lymphocytes and the development of opportunistic infections.

34 ell immune deficiency, and susceptibility to opportunistic infections.

35 s a pathogenic fungus responsible for severe opportunistic infections.

36 identified 100 consecutive IBD patients with opportunistic infections.

37 ociated with mortality in other AIDS-related opportunistic infections.

38 ociated invariant T (MAIT) cells help combat opportunistic infections.

39 pathogens that may predispose individuals to opportunistic infections.

40 aths from HIV-1 associated complications and opportunistic infections.

41 , an injury that increases susceptibility to opportunistic infections.

42 d HIV-positive patients without neoplasia or opportunistic infections.

43 ociated with mortality in other AIDS-related opportunistic infections.

44 cipally graft-versus-host disease (GVHD) and opportunistic infections.

45 y represent a therapeutic target for chronic opportunistic infections.

46 ts in increased susceptibility to secondary (opportunistic) infections.

47 IV-positive individuals without neoplasia or opportunistic infection (1.2%; P < .001).

48 ction and 4 during open-label therapy) and 3 opportunistic infections (1 in each group during double-

49 re lymphopenia (82%), neutropenia (47%), and opportunistic infections (13%).

50 (52.4%), noninfectious enteropathy (23.1%), opportunistic infections (15.7%), autoinflammation (29.6

51 ociated vasculopathy (24 [38%]), followed by opportunistic infections (16 [25%]).

52 s hospitalizations (28% vs 26%, P = .85), or opportunistic infections (16% vs 12%, P = .72).

53 s 25%; difference, 3% [95% CI, -9% to 15%]), opportunistic infections (25% vs 27%; difference, 2% [95

54 s, 2 cases of tuberculosis, 2 cases of other opportunistic infections, 3 cardiovascular events, and 4

55 ose for patients with AIDS without an ocular opportunistic infection (4.1 deaths/100 PY); toxoplasmic

56 Of 1825 participants with AIDS and no ocular opportunistic infections, 9.9% had intermediate-stage AM

57 reflects pathogenic immune responses against opportunistic infections acquired during the period of i

58 Rates of acute rejection, opportunistic infections, adverse events, CMV UL97 ganci

59 Nocardiosis is a rare, life-threatening opportunistic infection, affecting 0.04% to 3.5% of pati

60 Cytomegalovirus (CMV) is the most prevalent opportunistic infection after lung transplantation.

61 Cytomegalovirus (CMV) is a common opportunistic infection after solid organ transplantatio

62 Cytomegalovirus (CMV) is the most common opportunistic infection after solid-organ transplant.

63 both vaccine efficacy and protection against opportunistic infections after HSCT.

64 ge, HIV infection, illicit drug use, and CNS opportunistic infections all can affect brain structure,

65 Cytomegalovirus (CMV) retinitis is a common opportunistic infection among patients with AIDS and sti

66 The most common opportunistic infections among children with JIA were 3

67 Cestodes are emerging agents of severe opportunistic infections among immunocompromised patient

68 (HIV) disease under ineffective treatment of opportunistic infection and antiretroviral therapy (ART)

69 protect an immunocompromised host against an opportunistic infection and can be extended to other mic

70 e periphery are tightly regulated to prevent opportunistic infections and aberrant inflammation.

71 killer (NK)-cell lymphopenia associated with opportunistic infections and cancers.

72 been based on clinical indications, such as opportunistic infections and CD4 cell counts.

73 r special populations and in the settings of opportunistic infections and concomitant conditions are

74 Opportunistic infections and deaths are less common amon

75 n human immunodeficiency virus (HIV)-related opportunistic infections and deaths in US youth, but bot

76 oses the central nervous system to damage by opportunistic infections and environmental insults.

77 ICL predisposes patients to severe opportunistic infections and frequently leads to poor va

78 erpesvirus infections contribute to risk for opportunistic infections and graft rejection.

79 ICL confers an increased risk of opportunistic infections and has no established treatmen

80 erium nucleatum has long been found to cause opportunistic infections and has recently been implicate

81 ications such as increased susceptibility to opportunistic infections and inadequate healing of wound

82 depletion is linked directly to the risk for opportunistic infections and infection-associated mortal

83 d imposes unintended adverse effects such as opportunistic infections and malignancy that limit the h

84 uated both metrics as predictors of incident opportunistic infections and mortality.

85 on of affected infants before development of opportunistic infections and other complications.

86 that expose patients to an increased risk of opportunistic infections and other complications.

87 Other opportunistic infections and outcomes were not significa

88 olism that contributes to increased rates of opportunistic infections and sepsis in alcoholics.

89 ated stigma, decreased CD4 levels, increased opportunistic infections and sociodemographic variables.

90 grin alphaMbeta2 or alphaXbeta2 to deal with opportunistic infections and the capacity of cells deriv

91 nically relevant boost of immunity to reduce opportunistic infections and to increase graft-versus-le

92 etected in 88% of Asian adults with multiple opportunistic infections and were associated with an adu

93 icities, hemophagocytic lymphohistiocytosis, opportunistic infections, and endocrinopathies.

94 cells, leading to profound immunodeficiency, opportunistic infections, and eventually death.

95 presented with severe pancytopenia, multiple opportunistic infections, and features suggestive of cGV

96 mmune system dysfunction, a higher burden of opportunistic infections, and metabolic derangements.

97 l controlled HIV infection on ART, no active opportunistic infections, and minimum CD4 T-cell counts

98 AIDS-related stigma, CD4 levels, presence of opportunistic infections, and sociodemographic variables

99 thogenic bacteria, control of gut-associated opportunistic infections, and survival of SIV-infected R

100 t of pulmonary alveolar proteinosis or other opportunistic infections, and that patients may benefit

101 tween adaptation to natural environments and opportunistic infections, and that selection on specific

102 raphics, viral loads, CD4 counts, history of opportunistic infections, and vascular risks.

103 ities, such as dyslipidemia, drug abuse, and opportunistic infections; and lifestyle are risk factors

104 ated CD4(+) T-cell response against residual opportunistic infection antigen.

105 HIV-associated vasculopathy and opportunistic infections are common causes of HIV-relate

106 Opportunistic infections are generally ascribed to defec

107 by the fact that the symptoms and associated opportunistic infections are highly varied.

108 ive and potent DHFR inhibitors against these opportunistic infections are presented.

109 Opportunistic infections are rare among children with JI

110 ection in humans leads to the development of opportunistic infections as well as increased rates of b

111 the commensal fungus Candida albicans, is an opportunistic infection associated with infancy, AIDS, a

112 Microsporidia, a latent opportunistic infection associated with mild inflammatio

113 ving the host vulnerable to life-threatening opportunistic infections associated with AIDS.

114 an HIV infection, T cell exhaustion leads to opportunistic infections associated with AIDS.

115 In contrast to most other opportunistic infections associated with HIV, an increas

116 ated with acceptable and manageable risks of opportunistic infections associated with these cytokines

117 positive patients who did not have an ocular opportunistic infection at enrollment.

118 aluated data for participants without ocular opportunistic infections at initial examination (baselin

119 2) in the modern era, C. trachomatis causes "opportunistic" infection at non-GI sites under condition

120 lin administration and/or increased onset of opportunistic infections attributable to induced global

121 kages with an increase in diseases including opportunistic infections, autoimmunity, and incidence/bu

122 severity of illness, only the presence of an opportunistic infection before hospital admission was in

123 AIDS Society, Conference on Retroviruses and Opportunistic Infections, between 1996 to May 2013.

124 amma are associated with severe disseminated opportunistic infection, but their importance and preval

125 Morphine increases the susceptibility to opportunistic infection by attenuating bacterial clearan

126 ion of these patients has led to the rise of opportunistic infections by organisms that are recalcitr

127 g enterobacteria may help human hosts resist opportunistic infections by Pseudomonas and other pyoche

128 Most opportunistic infections can be recognised by a combinat

129 Retinal opportunistic infections can occur in patients with aqua

130 opharyngeal candidiasis (OPC [thrush]) is an opportunistic infection caused by the commensal fungus C

131 Opportunistic infections caused by pathogens associated

132 ate, five NPs developed AIDS associated with opportunistic infections caused by Pneumocystis carinii,

133 Opportunistic infections caused by Pneumocystis jiroveci

134 iding clinical care to start prophylaxis for opportunistic infections, CD4 counts should cease to be

135 -related CNS disorders (ARCD; e.g. prior CNS opportunistic infection), cerebrovascular disease (CVD)

136 system (CNS) disorders (ARCD; eg, prior CNS opportunistic infection), cerebrovascular disease (CVD),

137 ugh activated T cells from the patients with opportunistic infections demonstrated impaired mitochond

138 Eight patients with GS had opportunistic infections, despite normal peripheral CD4(

139 for clinical outcomes after UCBT, including opportunistic infections, disease relapse, and overall s

140 s developing advanced disease and associated opportunistic infections due to a failure to effectively

141 Although opportunistic infections due to Mycobacterium avium comp

142 PML and another 343 who did not suffer this opportunistic infection during natalizumab treatment.

143 ributes to the protection of gut mucosa from opportunistic infections during the course of SIV infect

144 here were no treatment-related deaths or new opportunistic infections during treatment, and patients

145 Mucormycosis has emerged as an important opportunistic infection, especially in severely immunosu

146 No patients in either group had opportunistic infections (excluding oral candidiasis and

147 sma gondii is a major food-borne illness and opportunistic infection for the immunosuppressed.

148 ter measles is known to predispose people to opportunistic infections for a period of several weeks t

149 se severity, CMV infection, acute rejection, opportunistic infections, ganciclovir resistance, and sa

150 Group for the Study of Kaposi's Sarcoma and Opportunistic infections (GHESKIO) Clinic in Port-au-Pri

151 sk of acute and chronic allograft rejection, opportunistic infection, graft failure, and patient mort

152 ttributable to viral reactivation (including opportunistic infection, graft rejection and severe hepa

153 outcomes included acute allograft rejection, opportunistic infections, graft and patient survival, an

154 l acquired immunodeficiency syndrome-related opportunistic infections has decreased with successful a

155 ve multifocal leukoencephalopathy, other CNS opportunistic infections have been rarely reported durin

156 T, specific antiretroviral drugs, history of opportunistic infection, immune status, or duration of a

157 reas Toxoplasma gondii is a life-threatening opportunistic infection in AIDS patients.

158 Overall, 15 (41.6%) developed an opportunistic infection in follow-up, 5 (13.8%) of which

159 n of oral mucosal tissue, is the most common opportunistic infection in HIV(+) and immunocompromised

160 ion, and risk of developing an AIDS-defining opportunistic infection in HIV-infected men.

161 tis jirovecii pneumonia (PCP), the commonest opportunistic infection in HIV-infected patients in the

162 Tuberculosis (TB) is the most common opportunistic infection in human immunodeficiency virus

163 United States and frequently presents as an opportunistic infection in immunocompromised hosts.

164 f severe diarrheal disease in infants and an opportunistic infection in immunocompromised patients, C

165 Cytomegalovirus is the most common viral opportunistic infection in immunocompromised patients.

166 that causes cryptococcosis, which is a major opportunistic infection in immunosuppressed individuals.

167 r, pneumococcal pneumonia is the most common opportunistic infection in individuals with HAND.

168 Cytomegalovirus retinitis is an uncommon opportunistic infection in kidney transplant recipients.

169 ed that invasive aspergillosis, a prototypic opportunistic infection in neutropenic hosts, is associa

170 Cytomegalovirus (CMV) is a late-stage opportunistic infection in people living with human immu

171 -transplant tuberculosis (PTTB) is a serious opportunistic infection in renal graft recipients with a

172 Tuberculosis (TB) is a significant opportunistic infection in solid organ transplant recipi

173 Pneumocystis pneumonia remains a common opportunistic infection in the diverse immunosuppressed

174 Cryptococcus species are known agents of opportunistic infections in healthy and immunocompromise

175 n Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adol

176 Diagnosis of opportunistic infections in HIV-infected individuals rem

177 might have therapeutic potential to prevent opportunistic infections in HIV-infected patients.

178 d be important in susceptibility to specific opportunistic infections in HIV.

179 is a common cause of antimicrobial-resistant opportunistic infections in hospitalized patients.

180 of warm-blooded vertebrates that also causes opportunistic infections in humans.

181 asive environmental bacterium that can cause opportunistic infections in humans.

182 They also cause life-threatening opportunistic infections in immunocompromised individual

183 c Gram-negative bacterium that causes severe opportunistic infections in immunocompromised individual

184 ally true for environmental fungi that cause opportunistic infections in immunocompromised patients s

185 tion could represent individuals with occult opportunistic infections in need of additional screening

186 ociated with an increased risk of common and opportunistic infections in patients with iNHL.

187 e bacterium can cause a wide range of severe opportunistic infections in patients with serious underl

188 dies may be important in the pathogenesis of opportunistic infections in patients with thymic maligna

189 ularly pigs and ruminants, and causes severe opportunistic infections in people.

190 4+ T cell lymphopenia of unknown origin, and opportunistic infections in some patients.

191 gest to specifically include reactivated and opportunistic infections in the differential diagnosis o

192 Opportunistic infections included viral in 15.3%, fungal

193 Opportunistic infections including cytomegalovirus (CMV)

194 transplant (SOT) recipients are at risk for opportunistic infections including tuberculosis.

195 less, children with JIA had a higher rate of opportunistic infections, including an increased rate of

196 ities that are not typical of HIV-associated opportunistic infections, including growth impairment an

197 age niche that is associated with a range of opportunistic infections, including infectious endocardi

198 D40 ligand (CD40L) deficiency predisposes to opportunistic infections, including those caused by fung

199 fected patients with underlying neoplasia or opportunistic infections, including tuberculosis.

200 The risk for HIV-associated opportunistic infections increases as circulating CD4+ l

201 y protocols that defined prophylaxis against opportunistic infection, indications for biopsy, and acc

202 This opportunistic infection is highly refractory to conventi

203 During HIV infection, the timing of opportunistic infections is not always associated with s

204 In the era of HAART, diarrhea from opportunistic infections is uncommon, and HIV-associated

205 tion, restoring CD4+ T cells, and preventing opportunistic infection, it appeared inadequate in rever

206 d antiretroviral (ARV) drug use with risk of opportunistic infections, key clinical events, and morta

207 e prophylaxis prolongs survival and prevents opportunistic infections, malaria, and diarrhea in perso

208 No cases of tuberculosis, opportunistic infections, malignancies, lymphomas, lupus

209 Strategies aimed at preventing this fatal opportunistic infection may improve outcomes.

210 Although uncommon, non-CMV ocular opportunistic infections may be associated with high rat

211 Besides HIV-1 itself, a number of opportunistic infections may cause renal disease in HIV-

212 By focusing on three common opportunistic infections (Mycobacterium tuberculosis, hu

213 es were mostly pneumonia (n = 157; 44.4%) or opportunistic infection (n = 76; 21.5%).

214 l candidiasis (OPC) is among the most common opportunistic infections observed in persons infected wi

215 Opportunistic infections occurred in 3 patients: 2 Pneum

216 No serious opportunistic infections occurred in ozanimod-treated pa

217 (odds ratio = 1.98 [1.07-3.65]; p = 0.03) or opportunistic infection (odds ratio = 4.75 [2.23-10.1];

218 (odds ratio = 2.34 [1.10-4.97]; p = 0.03) or opportunistic infection (odds ratio = 4.96 [2.11-11.6];

219 Opportunistic infection of oligodendrocytes by human JC

220 level persisting srni had more often a prior opportunistic infection of the central nervous system (C

221 level persisting SRNI more often had a prior opportunistic infection of the central nervous system (C

222 ltifocal leukoencephalopathy (PML) is a rare opportunistic infection of the central nervous system.

223 Oropharyngeal candidiasis (OPC) is an opportunistic infection of the oral mucosa caused by the

224 lectin I (PA-IL), a key protein involved in opportunistic infections of P. aeruginosa , and mouse ma

225 ysiology and act as virulence factors during opportunistic infections of plant and animal hosts.

226 g SRNI over time, characterized by more past opportunistic infections of the central nervous system,

227 Past opportunistic infections of the CNS, imperfect adherence

228 Past opportunistic infections of the CNS, imperfect adherence

229 ilus influenzae (NTHI) is a leading cause of opportunistic infections of the respiratory tract in chi

230 py (ART) is initiated after an AIDS-defining opportunistic infection (OI) is uncertain and understudi

231 y-proven acute rejection (BPAR), graft loss, opportunistic infections (OI), new-onset diabetes after

232 must be closely monitored for development of opportunistic infections (OI), such as cytomegalovirus.

233 ar immunity and increasing susceptibility to opportunistic infections (OI).

234 ew recent data on the rates of AIDS-defining opportunistic infections (OIs) among human immunodeficie

235 Knowledge of central nervous system (CNS) opportunistic infections (OIs) among people living with

236 evaluate the incidence and prevalence of 14 opportunistic infections (OIs) and other infections as w

237 retroviral therapy (ART) on incidence of key opportunistic infections (OIs) in human immunodeficiency

238 hs posttransplant and their correlation with opportunistic infections (OIs) in solid organ transplant

239 n was used; the frequency of the most common opportunistic infections (OIs) in the SHCS between MTB u

240 We aimed to review their association with opportunistic infections (OIs), including fungal, viral

241 was lowest in patients without a history of opportunistic infection or transfusions and who received

242 transplantation without an increased risk of opportunistic infections or cancer.

243 No opportunistic infections or deaths occurred.

244 ntrast sensitivity (in the absence of ocular opportunistic infections or media opacity), abnormalitie

245 units in either eye in the absence of ocular opportunistic infections or media opacity.

246 r of neurological symptoms in the absence of opportunistic infections or other co-morbidities, sugges

247 Excluding studies of opportunistic infections or prevention of mother-to-chil

248 xcellent survival for patients without prior opportunistic infections or transfusions and should be c

249 >10 years of age or those with a history of opportunistic infections or transfusions before HCT.

250 f biopsy-proven acute rejection, graft loss, opportunistic infections, or new-onset diabetes after tr

251 symptoms of immunodeficiency and evidence of opportunistic infections (Pneumocystis, Candida, and Myc

252 enic burden with antimicrobial treatment for opportunistic infections prior to starting ART.

253 bacteria and viruses that essentially become opportunistic infections promoting systemic immune activ

254 ART with opportunistic infection prophylaxis enables the delivery

255 thoprim-sulfamethoxazole (TMP-SMX), used for opportunistic infection prophylaxis in HIV-exposed infan

256 and HIV-uninfected, HIV-exposed children as opportunistic infection prophylaxis.

257 cute lung injury, the presence of a previous opportunistic infection, rather than traditional measure

258 or controls, according to the occurrence of opportunistic infection, recurring bacterial infections,

259 of aGVHD and cGVHD, low frequency of delayed opportunistic infections, reduced transfusion requiremen

260 the advances in antiretroviral therapy, CNS opportunistic infections remain a serious burden worldwi

261 There were no malignant neoplasms or opportunistic infections reported with BG-12.

262 Hematology patients with this opportunistic infection require integrated care across s

263 eumocystis pneumonia has become a late-onset opportunistic infection requiring indications for prolon

264 profound immune suppression, and consequent opportunistic infection results in high morbidity and mo

265 was a statistically significant predictor of opportunistic infection risk.

266 infection among atopic patients as caused by opportunistic infections secondary to airway inflammatio

267 All patients with opportunistic infection showed multiple anti-cytokine au

268 The ability to diagnose HIV and opportunistic infections simultaneously at the point of

269 onal models that excluded case patients with opportunistic infections, sTNFR-1, sCD27, and sCD40L wer

270 5% confidence interval {CI}, 1.21-4.85]) and opportunistic infections such as cytomegalovirus (HR, 3.

271 cell dysfunctions causing susceptibility to opportunistic infections such as Pneumocystis murina pne

272 in immunodeficiencies and susceptibility to opportunistic infections, such as Pneumocystis.

273 Baseline CD4 counts and screening for opportunistic infections, such as tuberculosis and crypt

274 lier among patients with AIDS free of ocular opportunistic infections than in the general population.

275 Toxoplasma gondii is an opportunistic infection that can cause severe neurologic

276 ulated fungus that causes cryptococcosis, an opportunistic infection that has recently been associate

277 Cytomegalovirus (CMV) is the most prevalent opportunistic infection that occurs in lung-transplant r

278 stis pneumonia (PCP) is a potentially lethal opportunistic infection that primary prophylaxis can hel

279 Fungi are major contributors to the opportunistic infections that affect patients with HIV/A

280 mely common airway commensal which can cause opportunistic infections that are usually localized to a

281 approach is the potential predisposition to opportunistic infections that might outweigh any clinica

282 ocused on the management of HIV/AIDS-related opportunistic infections that occur in the United States

283 ions from the Conference on Retroviruses and Opportunistic Infections, the International AIDS Society

284 We defined 15 types of opportunistic infection using physician diagnosis or hos

285 in stroke via several mechanisms, including opportunistic infection, vasculopathy, cardioembolism, a

286 er nAPCsr, and a lower ETP, while history of opportunistic infection was associated with a higher nAP

287 Once an ocular opportunistic infection was diagnosed, patients were see

288 ol, pack per year of smoking, and history of opportunistic infection were associated with baseline pl

289 When all opportunistic infections were considered together as a s

290 At enrollment, 37 non-CMV ocular opportunistic infections were diagnosed: 16 patients, he

291 Opportunistic infections were more frequent following FC

292 No opportunistic infections were noted, and only 3 infectio

293 incidence of other adverse events, including opportunistic infections, were similar during the second

294 In contrast, maternal co-opportunistic infection with primary or reactivated cyto

295 ified with regard to the risk of serious and opportunistic infections with biologic therapy.

296 In addition, opportunistic infections with Citrobacter species or Kle

297 y impair protective immunity against certain opportunistic infections with progression to AIDS.

298 ; Mycobacterium tuberculosis was the leading opportunistic infection, with more than half of patients

299 nfection (group 1); 45 patients with another opportunistic infection, with or without nontuberculous

300 immunodeficiency virus (HIV) and associated opportunistic infections would be expected to decline.